
Technical analysis of Biogen Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
Biogen Inc. is a pharmaceutical company that discovers, develops, manufactures, and delivers drugs and therapies in the healthcare sector, with a global presence in the United States, Europe, Asia, and internationally. Its product portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, postpartum depression, lymphomas, leukemia, and other neurological and immunological conditions, as well as biosimilar medicines. The company operates through collaborations and licensing agreements with numerous pharmaceutical and biotechnology partners.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the BIIB analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is Biogen Inc. analysed technically?
Technical analysis of Biogen Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Biogen Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Biogen Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Biogen Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.